<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-Y747JF1G</identifier><date>2015</date><creator>Boc, Marko</creator><creator>Kikec, Zdenko</creator><creator>Slemenik-Pušnik, Cirila</creator><creator>Vujasinović, Miroslav</creator><relation>documents/doc/Y/URN_NBN_SI_doc-Y747JF1G_001.pdf</relation><relation>documents/doc/Y/URN_NBN_SI_doc-Y747JF1G_001.txt</relation><format format_type="issue">1</format><format format_type="volume">19</format><format format_type="type">article</format><format format_type="extent">str. 33-34, 38</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">2140283</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-Y747JF1G</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">kapecitabin</subject><subject language_type_id="slv">kardiotoksičnost</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">miokardni infarkt</subject><subject language_type_id="slv">srčni infarkt</subject><title>S kapecitabinom povzročen transmuralni miokardni infarkt</title></Record>